Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedUpdate to site revision: Revision: v3.6.3 replaces the prior Revision: v3.6.2. This appears to be a behind-the-scenes platform update and does not modify study content or user workflows.SummaryDifference0.1%

- Check16 days agoChange DetectedA new revision tag v3.6.2 appears on the page, while the previous tag v3.6.0 is removed. This indicates an update to the page's revision/version rather than changes to study content.SummaryDifference0.1%

- Check30 days agoChange DetectedThe study page now includes new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a formatting adjustment to the Intervention/Treatment header, along with an updated revision tag (Revision: v3.6.0). The recruitment status has changed to 'No longer looking for participants,' signaling that enrollment is closed.SummaryDifference0.4%

- Check37 days agoChange DetectedThe revision label was updated from v3.5.4 to v3.5.5, signaling a small maintenance update to the page version history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's revision tag was updated to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.